News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
698,287 Results
Type
Article (40219)
Company Profile (250)
Press Release (657818)
Section
Business (204599)
Career Advice (2071)
Deals (35476)
Drug Delivery (100)
Drug Development (81252)
Employer Resources (173)
FDA (16200)
Job Trends (14904)
News (345996)
Policy (32668)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2570)
Accelerated approval (2)
Adcomms (21)
Allergies (80)
Alliances (49498)
ALS (81)
Alzheimer's disease (1349)
Antibody-drug conjugate (ADC) (108)
Approvals (16200)
Artificial intelligence (226)
Autoimmune disease (13)
Automation (14)
Bankruptcy (360)
Best Places to Work (11675)
BIOSECURE Act (18)
Biosimilars (101)
Biotechnology (177)
Bladder cancer (56)
Brain cancer (24)
Breast cancer (247)
Cancer (1974)
Cardiovascular disease (156)
Career advice (1727)
Career pathing (29)
CAR-T (144)
Cell therapy (399)
Cervical cancer (18)
Clinical research (65857)
Collaboration (763)
Compensation (446)
Complete response letters (19)
COVID-19 (2607)
CRISPR (34)
C-suite (204)
Cystic fibrosis (99)
Data (1921)
Decentralized trials (2)
Denatured (16)
Depression (37)
Diabetes (247)
Diagnostics (6347)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (111)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (85)
Earnings (86244)
Editorial (32)
Employer branding (21)
Employer resources (147)
Events (111905)
Executive appointments (629)
FDA (17297)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (683)
Gene editing (94)
Generative AI (18)
Gene therapy (276)
GLP-1 (682)
Government (4409)
Grass and pollen (4)
Guidances (48)
Healthcare (18886)
Huntington's disease (22)
IgA nephropathy (21)
Immunology and inflammation (102)
Indications (26)
Infectious disease (2736)
Inflammatory bowel disease (131)
Inflation Reduction Act (8)
Influenza (46)
Intellectual property (83)
Interviews (330)
IPO (16508)
IRA (40)
Job creations (3652)
Job search strategy (1461)
Kidney cancer (9)
Labor market (34)
Layoffs (451)
Leadership (15)
Legal (7955)
Liver cancer (70)
Lung cancer (290)
Lymphoma (129)
Machine learning (2)
Management (59)
Manufacturing (269)
MASH (60)
Medical device (13338)
Medtech (13343)
Mergers & acquisitions (19435)
Metabolic disorders (630)
Multiple sclerosis (69)
NASH (16)
Neurodegenerative disease (75)
Neuropsychiatric disorders (24)
Neuroscience (1813)
NextGen: Class of 2025 (6556)
Non-profit (4511)
Northern California (2396)
Now hiring (37)
Obesity (341)
Opinion (206)
Ovarian cancer (72)
Pain (75)
Pancreatic cancer (76)
Parkinson's disease (130)
Partnered (20)
Patents (201)
Patient recruitment (93)
Peanut (46)
People (57232)
Pharmaceutical (64)
Pharmacy benefit managers (19)
Phase I (20507)
Phase II (28996)
Phase III (21620)
Pipeline (973)
Podcasts (46)
Policy (109)
Postmarket research (2577)
Preclinical (8659)
Press Release (64)
Prostate cancer (92)
Psychedelics (31)
Radiopharmaceuticals (244)
Rare diseases (353)
Real estate (5935)
Recruiting (65)
Regulatory (22213)
Reports (46)
Research institute (2337)
Resumes & cover letters (358)
Rett syndrome (3)
RNA editing (3)
RSV (37)
Schizophrenia (63)
Series A (120)
Series B (77)
Service/supplier (11)
Sickle cell disease (49)
Southern California (2067)
Special edition (14)
Spinal muscular atrophy (148)
Sponsored (28)
Startups (3585)
State (2)
Stomach cancer (13)
Supply chain (59)
The Weekly (27)
United States (20932)
Vaccines (662)
Venture capitalists (37)
Webinars (12)
Weight loss (225)
Women's health (33)
Worklife (15)
Date
Today (125)
Last 7 days (601)
Last 30 days (2528)
Last 365 days (33647)
2025 (7758)
2024 (35286)
2023 (40138)
2022 (51258)
2021 (55811)
2020 (54212)
2019 (46725)
2018 (35164)
2017 (32216)
2016 (31626)
2015 (37716)
2014 (31438)
2013 (26466)
2012 (28680)
2011 (29401)
2010 (27436)
Location
Africa (731)
Alabama (49)
Alaska (7)
Arizona (223)
Arkansas (13)
Asia (37888)
Australia (6196)
California (5459)
Canada (1860)
China (468)
Colorado (244)
Connecticut (256)
Delaware (125)
Europe (81381)
Florida (810)
Georgia (190)
Idaho (58)
Illinois (490)
India (23)
Indiana (290)
Iowa (9)
Japan (140)
Kansas (100)
Kentucky (23)
Louisiana (7)
Maine (61)
Maryland (824)
Massachusetts (4106)
Michigan (209)
Minnesota (366)
Mississippi (2)
Missouri (75)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (62)
New Jersey (1558)
New Mexico (28)
New York (1566)
North Carolina (917)
North Dakota (7)
Northern California (2396)
Ohio (191)
Oklahoma (14)
Oregon (33)
Pennsylvania (1244)
Puerto Rico (9)
Rhode Island (26)
South America (1108)
South Carolina (19)
South Dakota (1)
Southern California (2067)
Tennessee (92)
Texas (814)
Utah (163)
Virginia (128)
Washington D.C. (57)
Washington State (510)
West Virginia (3)
Wisconsin (49)
698,287 Results for "forty seven inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Novartis to present new data at AAN, including seven-year disability outcomes and safety analysis of Kesimpta® in people with relapsing multiple sclerosis
March 25, 2025
·
5 min read
Pharm Country
PharmaNest to Present Seven Digital Pathology and AI Communications and Abstracts at the International Liver Congress — EASL 2024, Including Analytical and Clinical Validation
PharmaNest Inc. announces today that it will present, alongside its collaborators, seven abstracts at this year’s International Liver Congress - EASL in Milan, Italy, June 5-8, 2024.
June 3, 2024
·
3 min read
Press Releases
Cancer Grand Challenges Announces Seven New Challenges Representing Some of the Toughest Questions Facing Cancer Research Today
March 6, 2025
·
7 min read
Press Releases
Cardio Diagnostics Expands the Reach of its AI-Driven Precision Cardiovascular Medicine Tests by Partnering with Seven New Provider Organizations
February 4, 2025
·
5 min read
Press Releases
Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study
Initial patient enrollment anticipated during first quarter of 2025
December 19, 2024
·
8 min read
Job Trends
7 Companies Hiring in Indiana
Looking for a biopharma job in Indiana? Check out the
BioSpace
list of seven companies hiring life sciences professionals like you.
March 27, 2025
·
1 min read
·
Angela Gabriel
Grifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven years
Grifols, one of the world’s leading producers of plasma-derived medicines, announced that Biotest, a Grifols Group company, forecasts approximately USD 1 billion in revenue from sales in the United States of its intravenous immunoglobulin Yimmugo® during the next seven years, following recent Food and Drug Administration approval to treat primary immunodeficiencies.
July 1, 2024
·
7 min read
Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution
Endo International plc announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), is expanding its voluntary recall to include seven lots of Treprostinil Injection 20mg/20mL (1mg/mL) to the consumer level. The product is being recalled due to the potential for the presence of silicone particulates in the product.
April 22, 2024
·
5 min read
Biotech Bay
Talphera Announces Reduction in Size of its Board of Directors from Ten to Seven Members
Talphera, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, announced as part of its commitment to operating with best practices in corporate governance, its Board of Directors has decided to reduce the size of the Board from ten to seven directors.
March 1, 2024
·
5 min read
Genetown
BostonGene Announces Seven Abstract Acceptances at the 2024 American Society of Clinical Oncology Annual Meeting
BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, today announced that seven abstracts have been accepted for the 2024 ASCO Annual Meeting (ASCO), scheduled to take place May 31 – June 3, 2024, at McCormick Place Convention Center in Chicago, IL.
May 29, 2024
·
6 min read
1 of 69,829
Next
